| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 108 | 2016 | 4437 | 4.150 |
Why?
|
| Arteriosclerosis | 20 | 2005 | 1064 | 1.550 |
Why?
|
| E-Selectin | 32 | 2004 | 576 | 1.450 |
Why?
|
| Endothelium | 56 | 1991 | 764 | 1.060 |
Why?
|
| Interleukin-1 | 35 | 2005 | 1250 | 1.010 |
Why?
|
| Hemodynamics | 19 | 2016 | 4169 | 0.910 |
Why?
|
| Cell Adhesion | 44 | 2004 | 3096 | 0.900 |
Why?
|
| Umbilical Veins | 53 | 2005 | 426 | 0.840 |
Why?
|
| Cell Adhesion Molecules | 34 | 2003 | 1602 | 0.760 |
Why?
|
| Stress, Mechanical | 31 | 2012 | 1666 | 0.710 |
Why?
|
| Leukocytes | 15 | 2003 | 2030 | 0.700 |
Why?
|
| Muscle, Smooth, Vascular | 35 | 2001 | 1484 | 0.620 |
Why?
|
| Atherosclerosis | 5 | 2016 | 3524 | 0.590 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 25 | 2003 | 694 | 0.570 |
Why?
|
| Cells, Cultured | 114 | 2007 | 18968 | 0.560 |
Why?
|
| Neutrophils | 21 | 2000 | 3770 | 0.440 |
Why?
|
| Gene Expression Regulation | 24 | 2012 | 11902 | 0.420 |
Why?
|
| Platelet-Derived Growth Factor | 10 | 1998 | 617 | 0.410 |
Why?
|
| Interleukin-8 | 10 | 2002 | 698 | 0.370 |
Why?
|
| Angiotensin II | 18 | 1987 | 850 | 0.300 |
Why?
|
| Lysophosphatidylcholines | 4 | 1995 | 77 | 0.300 |
Why?
|
| Trans-Activators | 9 | 2005 | 2861 | 0.270 |
Why?
|
| Rheology | 8 | 1997 | 348 | 0.270 |
Why?
|
| Antigens, Surface | 11 | 1989 | 1616 | 0.270 |
Why?
|
| Blood Circulation | 2 | 2006 | 249 | 0.270 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2007 | 704 | 0.270 |
Why?
|
| Blood Vessels | 12 | 1987 | 1112 | 0.270 |
Why?
|
| Hemorheology | 4 | 2005 | 144 | 0.270 |
Why?
|
| Cattle | 29 | 2005 | 3847 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 1246 | 0.260 |
Why?
|
| Monocytes | 14 | 2002 | 2574 | 0.260 |
Why?
|
| Cell Communication | 9 | 2000 | 1642 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 15 | 2004 | 1128 | 0.240 |
Why?
|
| Endothelial Cells | 2 | 2016 | 3537 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2007 | 2866 | 0.240 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 376 | 0.240 |
Why?
|
| DNA-Binding Proteins | 11 | 2002 | 9590 | 0.240 |
Why?
|
| Chemotactic Factors | 4 | 1992 | 196 | 0.230 |
Why?
|
| Transcription, Genetic | 16 | 2007 | 7593 | 0.230 |
Why?
|
| Type C Phospholipases | 2 | 2003 | 287 | 0.230 |
Why?
|
| Carotid Arteries | 2 | 2007 | 951 | 0.230 |
Why?
|
| Kruppel-Like Transcription Factors | 6 | 2012 | 503 | 0.230 |
Why?
|
| beta-Cyclodextrins | 1 | 2003 | 67 | 0.220 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2012 | 530 | 0.220 |
Why?
|
| Arteries | 4 | 2002 | 1126 | 0.210 |
Why?
|
| Animals | 121 | 2016 | 167940 | 0.210 |
Why?
|
| Membrane Microdomains | 1 | 2003 | 206 | 0.200 |
Why?
|
| Receptors, Angiotensin | 8 | 1987 | 141 | 0.200 |
Why?
|
| Cytokines | 13 | 2000 | 7345 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2001 | 459 | 0.200 |
Why?
|
| Epoprostenol | 9 | 1991 | 248 | 0.190 |
Why?
|
| Arachidonic Acids | 10 | 1991 | 294 | 0.190 |
Why?
|
| Glycoproteins | 9 | 1988 | 2208 | 0.190 |
Why?
|
| Microcirculation | 8 | 2001 | 1279 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2449 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 21 | 2005 | 4357 | 0.180 |
Why?
|
| Calcium | 18 | 1994 | 5726 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 4 | 2005 | 908 | 0.180 |
Why?
|
| Mechanoreceptors | 1 | 2001 | 187 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 478 | 0.170 |
Why?
|
| Actins | 6 | 2001 | 2049 | 0.170 |
Why?
|
| Cytoplasm | 3 | 2000 | 1518 | 0.170 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2002 | 318 | 0.170 |
Why?
|
| Immediate-Early Proteins | 2 | 1999 | 449 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 5 | 2000 | 1956 | 0.160 |
Why?
|
| Blood Flow Velocity | 6 | 2004 | 1375 | 0.160 |
Why?
|
| Thromboplastin | 5 | 2005 | 286 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2047 | 0.160 |
Why?
|
| Receptors, Adrenergic, alpha | 8 | 1986 | 146 | 0.160 |
Why?
|
| Signal Transduction | 13 | 2016 | 23363 | 0.150 |
Why?
|
| Inflammation | 11 | 2004 | 10757 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2000 | 4494 | 0.150 |
Why?
|
| Aorta | 17 | 2005 | 2042 | 0.150 |
Why?
|
| Enzyme Activation | 5 | 2007 | 3604 | 0.150 |
Why?
|
| Growth Substances | 4 | 1994 | 768 | 0.150 |
Why?
|
| DNA Primers | 6 | 2005 | 2819 | 0.150 |
Why?
|
| Antiporters | 1 | 1998 | 278 | 0.140 |
Why?
|
| Rabbits | 23 | 1998 | 4773 | 0.140 |
Why?
|
| Lipopolysaccharides | 7 | 2002 | 2214 | 0.140 |
Why?
|
| Leukotriene B4 | 4 | 1991 | 281 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 10 | 2005 | 5784 | 0.140 |
Why?
|
| Thrombin | 4 | 2005 | 593 | 0.140 |
Why?
|
| Bumetanide | 1 | 1997 | 96 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2000 | 490 | 0.140 |
Why?
|
| Flow Cytometry | 6 | 2005 | 5873 | 0.140 |
Why?
|
| Medical Oncology | 1 | 2009 | 2321 | 0.140 |
Why?
|
| Cell Movement | 9 | 2002 | 5206 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2002 | 2441 | 0.130 |
Why?
|
| NF-kappa B | 8 | 2004 | 2486 | 0.130 |
Why?
|
| Base Sequence | 16 | 2005 | 12447 | 0.130 |
Why?
|
| Receptors, Cell Surface | 6 | 1987 | 2825 | 0.130 |
Why?
|
| Humans | 145 | 2016 | 760261 | 0.130 |
Why?
|
| Mesenteric Arteries | 10 | 1986 | 178 | 0.130 |
Why?
|
| Phenotype | 7 | 2016 | 16543 | 0.130 |
Why?
|
| Cell Membrane | 11 | 2004 | 3683 | 0.120 |
Why?
|
| Culture Media | 9 | 2002 | 899 | 0.120 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 5 | 1990 | 224 | 0.120 |
Why?
|
| Molecular Sequence Data | 18 | 2001 | 17628 | 0.120 |
Why?
|
| HL-60 Cells | 3 | 2003 | 363 | 0.120 |
Why?
|
| RNA, Messenger | 16 | 2005 | 12762 | 0.120 |
Why?
|
| Cytoskeleton | 3 | 1996 | 1167 | 0.120 |
Why?
|
| Blood Platelets | 11 | 1991 | 2522 | 0.120 |
Why?
|
| Leukocytosis | 1 | 1996 | 251 | 0.120 |
Why?
|
| Myosins | 4 | 1984 | 405 | 0.120 |
Why?
|
| Hirudins | 1 | 1995 | 194 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 1996 | 594 | 0.110 |
Why?
|
| Platelet Adhesiveness | 4 | 1982 | 154 | 0.110 |
Why?
|
| Cytosol | 5 | 1992 | 887 | 0.110 |
Why?
|
| Recombinant Proteins | 11 | 1997 | 6543 | 0.110 |
Why?
|
| Leukocyte Adherence Inhibition Test | 2 | 1992 | 6 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2009 | 3421 | 0.110 |
Why?
|
| Isoenzymes | 2 | 2002 | 1690 | 0.110 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 1882 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 1997 | 4938 | 0.110 |
Why?
|
| Blood Coagulation | 6 | 2005 | 1156 | 0.110 |
Why?
|
| Regional Blood Flow | 4 | 2004 | 1490 | 0.100 |
Why?
|
| Platelet Activating Factor | 3 | 1990 | 143 | 0.100 |
Why?
|
| Nitric Oxide | 4 | 2016 | 2141 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1173 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2012 | 3333 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 3 | 1996 | 1828 | 0.100 |
Why?
|
| Phosphorylation | 7 | 2003 | 8314 | 0.100 |
Why?
|
| Membrane Glycoproteins | 7 | 1998 | 3731 | 0.090 |
Why?
|
| Gene Expression | 4 | 1999 | 7592 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2001 | 2895 | 0.090 |
Why?
|
| Kinetics | 21 | 2005 | 6378 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 17 | 2003 | 9196 | 0.090 |
Why?
|
| L-Selectin | 7 | 1998 | 209 | 0.090 |
Why?
|
| Interleukin-4 | 4 | 2002 | 1133 | 0.090 |
Why?
|
| Transcription Factors | 6 | 2002 | 12100 | 0.080 |
Why?
|
| Fibrinolysin | 1 | 1989 | 131 | 0.080 |
Why?
|
| Interferon-gamma | 9 | 2002 | 3160 | 0.080 |
Why?
|
| Up-Regulation | 5 | 2000 | 4127 | 0.080 |
Why?
|
| Endotoxins | 3 | 1988 | 521 | 0.080 |
Why?
|
| Muscle, Smooth | 6 | 2002 | 924 | 0.080 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 213 | 0.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 7 | 1995 | 819 | 0.080 |
Why?
|
| Bradykinin | 3 | 1986 | 208 | 0.080 |
Why?
|
| Tyrosine | 2 | 2003 | 1440 | 0.080 |
Why?
|
| Models, Cardiovascular | 2 | 2010 | 974 | 0.080 |
Why?
|
| Chemokine CCL2 | 3 | 2002 | 607 | 0.080 |
Why?
|
| Cross-Linking Reagents | 2 | 2003 | 685 | 0.080 |
Why?
|
| Amino Acid Sequence | 12 | 1998 | 13456 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2004 | 3774 | 0.070 |
Why?
|
| Cell Line | 9 | 2001 | 15626 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2009 | 2777 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 1 | 1987 | 94 | 0.070 |
Why?
|
| Homeostasis | 4 | 2007 | 3305 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 586 | 0.070 |
Why?
|
| Blood Physiological Phenomena | 1 | 1987 | 53 | 0.070 |
Why?
|
| Venules | 3 | 2001 | 164 | 0.070 |
Why?
|
| Glycerides | 4 | 1987 | 67 | 0.070 |
Why?
|
| Phospholipids | 6 | 1994 | 789 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2000 | 642 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2000 | 663 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-sis | 3 | 1998 | 256 | 0.070 |
Why?
|
| Smad2 Protein | 4 | 2000 | 145 | 0.070 |
Why?
|
| Diglycerides | 4 | 1987 | 176 | 0.070 |
Why?
|
| Interleukins | 2 | 1994 | 782 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2002 | 343 | 0.070 |
Why?
|
| Prostaglandin Endoperoxides | 2 | 1991 | 12 | 0.070 |
Why?
|
| Prostaglandins E | 2 | 1976 | 169 | 0.070 |
Why?
|
| Systems Biology | 1 | 2010 | 479 | 0.070 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 912 | 0.070 |
Why?
|
| Oligonucleotide Probes | 3 | 1996 | 418 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 1997 | 2218 | 0.070 |
Why?
|
| Macromolecular Substances | 3 | 2000 | 1433 | 0.060 |
Why?
|
| Rats | 33 | 2000 | 23695 | 0.060 |
Why?
|
| Granulocytes | 2 | 1993 | 551 | 0.060 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1993 | 0.060 |
Why?
|
| P-Selectin | 5 | 2004 | 600 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 1344 | 0.060 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 4 | 1993 | 221 | 0.060 |
Why?
|
| Endothelins | 2 | 1997 | 127 | 0.060 |
Why?
|
| Ligands | 3 | 2003 | 3277 | 0.060 |
Why?
|
| Phosphatidylinositols | 6 | 1987 | 282 | 0.060 |
Why?
|
| Pinocytosis | 2 | 1984 | 62 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 2641 | 0.060 |
Why?
|
| Vasopressins | 1 | 1986 | 355 | 0.060 |
Why?
|
| Blood Coagulation Factors | 2 | 1986 | 366 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2002 | 1755 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2004 | 1304 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2009 | 359 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2003 | 299 | 0.060 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2002 | 56 | 0.060 |
Why?
|
| Arachidonic Acid | 7 | 1991 | 434 | 0.060 |
Why?
|
| Antigens, Heterophile | 1 | 1984 | 70 | 0.060 |
Why?
|
| Fibronectins | 2 | 1984 | 721 | 0.060 |
Why?
|
| Sodium | 6 | 1987 | 1601 | 0.060 |
Why?
|
| Rats, Inbred Strains | 8 | 1987 | 2094 | 0.060 |
Why?
|
| Adenine Nucleotides | 2 | 1994 | 111 | 0.060 |
Why?
|
| Veins | 3 | 2001 | 765 | 0.060 |
Why?
|
| Caveolae | 1 | 2003 | 55 | 0.060 |
Why?
|
| Cyclodextrins | 1 | 2003 | 65 | 0.050 |
Why?
|
| Caveolins | 1 | 2003 | 102 | 0.050 |
Why?
|
| Guanine Nucleotides | 2 | 1984 | 55 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 130 | 0.050 |
Why?
|
| Cell Division | 10 | 2004 | 4462 | 0.050 |
Why?
|
| Carcinoma, Brown-Pearce | 2 | 1973 | 3 | 0.050 |
Why?
|
| Integrins | 4 | 2001 | 840 | 0.050 |
Why?
|
| Lung | 3 | 1997 | 9989 | 0.050 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2002 | 10 | 0.050 |
Why?
|
| Staurosporine | 2 | 2002 | 242 | 0.050 |
Why?
|
| Okadaic Acid | 1 | 2002 | 67 | 0.050 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 1997 | 104 | 0.050 |
Why?
|
| Norepinephrine | 7 | 1986 | 900 | 0.050 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2002 | 56 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1995 | 789 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2004 | 211 | 0.050 |
Why?
|
| Microscopy, Electron | 8 | 1986 | 2558 | 0.050 |
Why?
|
| Osmosis | 1 | 2002 | 103 | 0.050 |
Why?
|
| Cell Transformation, Viral | 2 | 1981 | 526 | 0.050 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2002 | 68 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2009 | 1576 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 1986 | 1446 | 0.050 |
Why?
|
| Antigens, CD | 7 | 1998 | 4002 | 0.050 |
Why?
|
| Binding Sites | 7 | 2005 | 6050 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2000 | 3800 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 2 | 1999 | 132 | 0.050 |
Why?
|
| Proteins | 3 | 2001 | 6030 | 0.050 |
Why?
|
| Perfusion | 5 | 2004 | 1376 | 0.050 |
Why?
|
| Son of Sevenless Protein, Drosophila | 1 | 2001 | 1 | 0.050 |
Why?
|
| Diet, Atherogenic | 2 | 1993 | 93 | 0.050 |
Why?
|
| COS Cells | 2 | 2001 | 1129 | 0.050 |
Why?
|
| Membrane Proteins | 4 | 2002 | 7854 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2003 | 257 | 0.050 |
Why?
|
| Complement C5a | 2 | 1992 | 100 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2001 | 101 | 0.050 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2001 | 68 | 0.050 |
Why?
|
| Lipoxygenase | 3 | 1987 | 72 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 1982 | 451 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 121 | 0.050 |
Why?
|
| Stimulation, Chemical | 4 | 1995 | 306 | 0.050 |
Why?
|
| Restriction Mapping | 4 | 2000 | 852 | 0.050 |
Why?
|
| Eye Neoplasms | 2 | 1974 | 306 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2002 | 320 | 0.050 |
Why?
|
| Simian virus 40 | 3 | 1981 | 291 | 0.050 |
Why?
|
| Fibrinogen | 1 | 1984 | 887 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 2222 | 0.050 |
Why?
|
| Electrolytes | 1 | 1982 | 280 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 1979 | 361 | 0.050 |
Why?
|
| Thyroid Gland | 3 | 1975 | 1169 | 0.050 |
Why?
|
| Cardiovascular System | 2 | 2000 | 850 | 0.050 |
Why?
|
| Dinoprostone | 2 | 2002 | 599 | 0.050 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2012 | 1520 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 1991 | 285 | 0.050 |
Why?
|
| Iris | 4 | 1976 | 231 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2001 | 225 | 0.050 |
Why?
|
| Colony-Stimulating Factors | 1 | 1980 | 218 | 0.040 |
Why?
|
| Aorta, Thoracic | 8 | 1989 | 1097 | 0.040 |
Why?
|
| Protein Transport | 2 | 2003 | 1966 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2002 | 10829 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 5 | 1992 | 2473 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 6 | 2000 | 6226 | 0.040 |
Why?
|
| Dactinomycin | 2 | 1994 | 306 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2002 | 371 | 0.040 |
Why?
|
| Arterioles | 1 | 2001 | 250 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 474 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2001 | 235 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2000 | 203 | 0.040 |
Why?
|
| Neoplasms | 2 | 2009 | 22066 | 0.040 |
Why?
|
| Pyridines | 2 | 2002 | 2877 | 0.040 |
Why?
|
| Botulinum Toxins | 1 | 2001 | 188 | 0.040 |
Why?
|
| Prazosin | 5 | 1986 | 95 | 0.040 |
Why?
|
| Vascular Diseases | 2 | 1998 | 1180 | 0.040 |
Why?
|
| Epitopes | 2 | 1991 | 2506 | 0.040 |
Why?
|
| Autoradiography | 5 | 1986 | 730 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 4 | 1989 | 1190 | 0.040 |
Why?
|
| Basophils | 2 | 1992 | 405 | 0.040 |
Why?
|
| Receptors, Leukocyte-Adhesion | 3 | 1999 | 52 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2000 | 283 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2001 | 706 | 0.040 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2000 | 143 | 0.040 |
Why?
|
| Molecular Weight | 5 | 1992 | 2186 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 3 | 1995 | 912 | 0.040 |
Why?
|
| Eicosanoic Acids | 2 | 1989 | 15 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 1991 | 635 | 0.040 |
Why?
|
| Mice | 21 | 2004 | 81216 | 0.040 |
Why?
|
| DNA | 11 | 1997 | 7236 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 285 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 2 | 2002 | 600 | 0.040 |
Why?
|
| Epidermal Growth Factor | 3 | 1994 | 695 | 0.040 |
Why?
|
| Prostaglandins | 4 | 1981 | 398 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2000 | 421 | 0.040 |
Why?
|
| Endothelin-1 | 2 | 1997 | 302 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 1992 | 662 | 0.040 |
Why?
|
| Chemokines | 1 | 2002 | 962 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 1996 | 2909 | 0.040 |
Why?
|
| Phosphoserine | 1 | 1998 | 203 | 0.040 |
Why?
|
| Organic Anion Transporters | 1 | 1998 | 100 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1992 | 1746 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2003 | 1033 | 0.040 |
Why?
|
| Mammary Glands, Animal | 2 | 1976 | 265 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 951 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2003 | 1048 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 12959 | 0.040 |
Why?
|
| Genetic Vectors | 4 | 2002 | 3378 | 0.040 |
Why?
|
| Thrombosis | 3 | 2005 | 3052 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 1791 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2001 | 562 | 0.040 |
Why?
|
| Catecholamines | 4 | 1982 | 385 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2004 | 2363 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 1998 | 191 | 0.040 |
Why?
|
| Transfection | 5 | 2005 | 5782 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 444 | 0.040 |
Why?
|
| Nocodazole | 1 | 1997 | 95 | 0.040 |
Why?
|
| Calcimycin | 5 | 1990 | 213 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1993 | 1056 | 0.040 |
Why?
|
| Membrane Potentials | 2 | 1992 | 1095 | 0.040 |
Why?
|
| Thymidine | 4 | 1984 | 299 | 0.040 |
Why?
|
| Immunohistochemistry | 7 | 2004 | 11064 | 0.040 |
Why?
|
| Receptors, Adrenergic | 3 | 1982 | 155 | 0.030 |
Why?
|
| Fibrinolysis | 2 | 1989 | 332 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1976 | 2823 | 0.030 |
Why?
|
| Microspheres | 2 | 1998 | 785 | 0.030 |
Why?
|
| Eosinophils | 2 | 1992 | 946 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2009 | 3903 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 1996 | 98 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9388 | 0.030 |
Why?
|
| RNA Splicing | 2 | 1991 | 914 | 0.030 |
Why?
|
| Yohimbine | 3 | 1985 | 62 | 0.030 |
Why?
|
| Phorbols | 2 | 1986 | 43 | 0.030 |
Why?
|
| Imidazoles | 1 | 2002 | 1178 | 0.030 |
Why?
|
| Immunomagnetic Separation | 1 | 1996 | 79 | 0.030 |
Why?
|
| Skin | 7 | 1998 | 4468 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 74269 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1997 | 301 | 0.030 |
Why?
|
| Neoplasm Transplantation | 6 | 1976 | 2014 | 0.030 |
Why?
|
| Gene Library | 1 | 1998 | 1060 | 0.030 |
Why?
|
| Cell Separation | 3 | 1996 | 1720 | 0.030 |
Why?
|
| Cytochalasin B | 2 | 1992 | 74 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1997 | 1135 | 0.030 |
Why?
|
| Extracellular Space | 3 | 1992 | 565 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 1297 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1984 | 1143 | 0.030 |
Why?
|
| Biological Transport | 3 | 1986 | 2087 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 2004 | 6067 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1994 | 1544 | 0.030 |
Why?
|
| Platelet Factor 4 | 2 | 1989 | 129 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 1995 | 1387 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 1975 | 79 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 29636 | 0.030 |
Why?
|
| ras Proteins | 1 | 2000 | 1051 | 0.030 |
Why?
|
| Nuclear Proteins | 3 | 1999 | 5793 | 0.030 |
Why?
|
| Macrophages | 4 | 2002 | 5745 | 0.030 |
Why?
|
| Male | 39 | 2009 | 359413 | 0.030 |
Why?
|
| Lymphocytes | 3 | 1996 | 2612 | 0.030 |
Why?
|
| Platelet Aggregation | 4 | 1991 | 805 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1976 | 279 | 0.030 |
Why?
|
| Research | 1 | 2003 | 1973 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 24086 | 0.030 |
Why?
|
| Protein Binding | 3 | 2001 | 9336 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1994 | 119 | 0.030 |
Why?
|
| Protein Kinase C | 5 | 1995 | 1201 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2000 | 2415 | 0.030 |
Why?
|
| Tritium | 5 | 1986 | 707 | 0.030 |
Why?
|
| Papio | 2 | 1986 | 661 | 0.030 |
Why?
|
| Aminoquinolines | 4 | 1987 | 108 | 0.030 |
Why?
|
| Liposomes | 1 | 1997 | 776 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2002 | 5039 | 0.030 |
Why?
|
| Phorbol Esters | 2 | 1990 | 108 | 0.030 |
Why?
|
| Muscle Contraction | 4 | 1985 | 1201 | 0.030 |
Why?
|
| Guanylyl Imidodiphosphate | 2 | 1983 | 37 | 0.030 |
Why?
|
| Cyclic GMP | 4 | 1987 | 395 | 0.030 |
Why?
|
| Cornea | 4 | 1978 | 1325 | 0.030 |
Why?
|
| Capillary Permeability | 3 | 2004 | 768 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1986 | 1061 | 0.030 |
Why?
|
| Antigens | 4 | 1987 | 1447 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1997 | 706 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1993 | 1388 | 0.030 |
Why?
|
| Potassium | 2 | 1987 | 1318 | 0.030 |
Why?
|
| Physical Stimulation | 1 | 1994 | 518 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1999 | 1343 | 0.030 |
Why?
|
| Precancerous Conditions | 2 | 1976 | 978 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2004 | 3046 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1999 | 1612 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 1 | 1992 | 286 | 0.020 |
Why?
|
| Adenoviridae | 3 | 2002 | 1084 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 1974 | 1229 | 0.020 |
Why?
|
| Histocytochemistry | 3 | 1986 | 693 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 2874 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 778 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 1980 | 2063 | 0.020 |
Why?
|
| Culture Techniques | 3 | 1976 | 530 | 0.020 |
Why?
|
| Aspirin | 5 | 1988 | 3365 | 0.020 |
Why?
|
| Magnesium | 3 | 1983 | 810 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 3 | 1989 | 80 | 0.020 |
Why?
|
| Microbial Collagenase | 3 | 1976 | 113 | 0.020 |
Why?
|
| Ionomycin | 1 | 1990 | 109 | 0.020 |
Why?
|
| Myocardium | 1 | 1983 | 4688 | 0.020 |
Why?
|
| Polymers | 2 | 2001 | 1620 | 0.020 |
Why?
|
| T-Lymphocytes | 5 | 1998 | 10183 | 0.020 |
Why?
|
| Time Factors | 10 | 1993 | 40133 | 0.020 |
Why?
|
| Mitogens | 2 | 1985 | 230 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2004 | 14396 | 0.020 |
Why?
|
| Iodine Radioisotopes | 3 | 1986 | 1032 | 0.020 |
Why?
|
| Cardiology | 1 | 2001 | 1723 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1976 | 2195 | 0.020 |
Why?
|
| Capillary Resistance | 1 | 1969 | 3 | 0.020 |
Why?
|
| Chemotaxis | 1 | 1992 | 598 | 0.020 |
Why?
|
| Plasminogen | 1 | 1989 | 146 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1992 | 641 | 0.020 |
Why?
|
| Smad6 Protein | 2 | 2000 | 14 | 0.020 |
Why?
|
| Apyrase | 1 | 1992 | 373 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1994 | 1995 | 0.020 |
Why?
|
| Internet | 1 | 2001 | 3074 | 0.020 |
Why?
|
| HLA Antigens | 2 | 1992 | 1369 | 0.020 |
Why?
|
| SRS-A | 2 | 1989 | 133 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1993 | 772 | 0.020 |
Why?
|
| Glucose | 1 | 1981 | 4361 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2003 | 1765 | 0.020 |
Why?
|
| Biological Factors | 1 | 1989 | 158 | 0.020 |
Why?
|
| Binding Sites, Antibody | 2 | 1986 | 337 | 0.020 |
Why?
|
| Gene Transfer Techniques | 3 | 1999 | 1204 | 0.020 |
Why?
|
| United States | 3 | 2009 | 72363 | 0.020 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1969 | 92 | 0.020 |
Why?
|
| Leukotrienes | 1 | 1990 | 234 | 0.020 |
Why?
|
| Inositol Phosphates | 2 | 1985 | 176 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1995 | 3969 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 1994 | 931 | 0.020 |
Why?
|
| Saphenous Vein | 2 | 1993 | 538 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 3735 | 0.020 |
Why?
|
| Radioisotopes | 2 | 1986 | 495 | 0.020 |
Why?
|
| Egtazic Acid | 2 | 1985 | 169 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1995 | 949 | 0.020 |
Why?
|
| Prostaglandins F | 2 | 1984 | 80 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2262 | 0.020 |
Why?
|
| Edema | 2 | 1988 | 772 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 1995 | 3207 | 0.020 |
Why?
|
| Calcium Radioisotopes | 1 | 1986 | 9 | 0.020 |
Why?
|
| Rubidium | 1 | 1986 | 122 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1994 | 1655 | 0.020 |
Why?
|
| Peptides | 1 | 1998 | 4358 | 0.020 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 1986 | 15 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1999 | 3335 | 0.020 |
Why?
|
| Monokines | 1 | 1986 | 71 | 0.020 |
Why?
|
| Phytohemagglutinins | 2 | 1983 | 168 | 0.020 |
Why?
|
| Adhesiveness | 1 | 1985 | 52 | 0.020 |
Why?
|
| Lipoxins | 1 | 1989 | 418 | 0.020 |
Why?
|
| Ouabain | 1 | 1986 | 247 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2005 | 3443 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 1998 | 736 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2001 | 8018 | 0.020 |
Why?
|
| Umbilical Cord | 2 | 1979 | 181 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1986 | 180 | 0.020 |
Why?
|
| Renin | 2 | 1985 | 636 | 0.020 |
Why?
|
| Sugar Phosphates | 1 | 1985 | 44 | 0.020 |
Why?
|
| Furosemide | 1 | 1986 | 170 | 0.020 |
Why?
|
| Vasoconstriction | 2 | 1986 | 592 | 0.020 |
Why?
|
| Cations | 2 | 1983 | 239 | 0.020 |
Why?
|
| Indomethacin | 2 | 1976 | 326 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1986 | 815 | 0.020 |
Why?
|
| Drug Interactions | 2 | 1988 | 1426 | 0.020 |
Why?
|
| Kidney | 2 | 1998 | 7072 | 0.020 |
Why?
|
| Mice, Inbred C3H | 2 | 1976 | 915 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1984 | 176 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 1984 | 1314 | 0.010 |
Why?
|
| Lymphokines | 1 | 1987 | 929 | 0.010 |
Why?
|
| Thrombomodulin | 1 | 2005 | 105 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1986 | 1455 | 0.010 |
Why?
|
| Thromboxane B2 | 1 | 1984 | 147 | 0.010 |
Why?
|
| Hydrolysis | 3 | 1993 | 665 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1991 | 1534 | 0.010 |
Why?
|
| Infant, Newborn | 4 | 1998 | 26168 | 0.010 |
Why?
|
| Interleukin-2 | 2 | 1988 | 1890 | 0.010 |
Why?
|
| Protective Agents | 1 | 2005 | 150 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1984 | 193 | 0.010 |
Why?
|
| Elastic Tissue | 1 | 1984 | 65 | 0.010 |
Why?
|
| Hemostasis | 1 | 1987 | 468 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 280 | 0.010 |
Why?
|
| Oscillometry | 1 | 1984 | 145 | 0.010 |
Why?
|
| Immune Sera | 1 | 1984 | 613 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1984 | 534 | 0.010 |
Why?
|
| Chlorides | 1 | 1986 | 666 | 0.010 |
Why?
|
| HLA-DR Antigens | 4 | 1986 | 630 | 0.010 |
Why?
|
| Dogs | 3 | 1975 | 3843 | 0.010 |
Why?
|
| Consensus Sequence | 2 | 1995 | 367 | 0.010 |
Why?
|
| Transplantation, Heterologous | 3 | 1976 | 2378 | 0.010 |
Why?
|
| Solubility | 1 | 1984 | 1088 | 0.010 |
Why?
|
| Triglycerides | 2 | 1993 | 2476 | 0.010 |
Why?
|
| Hydrostatic Pressure | 1 | 1982 | 95 | 0.010 |
Why?
|
| Ultrasonics | 1 | 2004 | 207 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 613 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2002 | 44 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 514 | 0.010 |
Why?
|
| Manganese | 2 | 1982 | 395 | 0.010 |
Why?
|
| Rotation | 1 | 1984 | 514 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 568 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Anterior Chamber | 2 | 1973 | 194 | 0.010 |
Why?
|
| Carbon | 3 | 1978 | 669 | 0.010 |
Why?
|
| Vasodilation | 1 | 1986 | 964 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1982 | 93 | 0.010 |
Why?
|
| Biological Products | 2 | 1988 | 914 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1982 | 398 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1981 | 35 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1981 | 50 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1982 | 316 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1984 | 928 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1984 | 674 | 0.010 |
Why?
|
| ADP Ribose Transferases | 1 | 2001 | 90 | 0.010 |
Why?
|
| Nitroprusside | 2 | 1995 | 273 | 0.010 |
Why?
|
| Prostaglandins H | 2 | 1991 | 23 | 0.010 |
Why?
|
| Ephrin-B2 | 1 | 2001 | 40 | 0.010 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1982 | 239 | 0.010 |
Why?
|
| Chromium Isotopes | 2 | 1972 | 29 | 0.010 |
Why?
|
| U937 Cells | 1 | 2001 | 262 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1984 | 967 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2005 | 673 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1984 | 1351 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 9283 | 0.010 |
Why?
|
| Sequence Alignment | 2 | 1997 | 2178 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1990 | 1549 | 0.010 |
Why?
|
| Academies and Institutes | 1 | 2003 | 319 | 0.010 |
Why?
|
| Uterus | 1 | 1984 | 651 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 251 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1981 | 174 | 0.010 |
Why?
|
| Dihydroergotoxine | 1 | 1980 | 21 | 0.010 |
Why?
|
| Sympathectomy | 1 | 1981 | 90 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1981 | 333 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 3 | 1997 | 6131 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 560 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2000 | 168 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 482 | 0.010 |
Why?
|
| Fibroblasts | 3 | 1986 | 4091 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1981 | 345 | 0.010 |
Why?
|
| Genomic Library | 1 | 2000 | 189 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1987 | 1805 | 0.010 |
Why?
|
| Platelet Count | 1 | 1982 | 777 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1981 | 446 | 0.010 |
Why?
|
| Muscles | 1 | 1984 | 1581 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 1999 | 149 | 0.010 |
Why?
|
| Computer Simulation | 1 | 1992 | 6210 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 2 | 1975 | 110 | 0.010 |
Why?
|
| Epinephrine | 4 | 1984 | 791 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2002 | 1340 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4573 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1987 | 2509 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 1998 | 87 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1993 | 796 | 0.010 |
Why?
|
| Plasminogen Inactivators | 2 | 1988 | 37 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 2000 | 622 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2000 | 897 | 0.010 |
Why?
|
| Smad7 Protein | 1 | 1997 | 40 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1697 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1984 | 1765 | 0.010 |
Why?
|
| Radioligand Assay | 3 | 1984 | 366 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 332 | 0.010 |
Why?
|
| Quinazolines | 1 | 1984 | 1363 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 1997 | 242 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 2117 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 652 | 0.010 |
Why?
|
| Female | 14 | 2000 | 391011 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 1997 | 140 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1976 | 151 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1430 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1982 | 1172 | 0.010 |
Why?
|
| Adenine | 1 | 1982 | 976 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13249 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 255 | 0.010 |
Why?
|
| Cell Nucleolus | 1 | 1976 | 156 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 489 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 2138 | 0.010 |
Why?
|
| HLA-DQ Antigens | 2 | 1988 | 211 | 0.010 |
Why?
|
| S-Nitrosoglutathione | 1 | 1995 | 23 | 0.010 |
Why?
|
| Molsidomine | 1 | 1995 | 22 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 22025 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 185 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1985 | 110 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1998 | 743 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1663 | 0.010 |
Why?
|
| Nitroso Compounds | 1 | 1995 | 71 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 1985 | 124 | 0.010 |
Why?
|
| Exons | 2 | 1991 | 2391 | 0.010 |
Why?
|
| Dithiothreitol | 2 | 1987 | 95 | 0.010 |
Why?
|
| Homozygote | 1 | 2000 | 1786 | 0.010 |
Why?
|
| Cell Survival | 1 | 1985 | 5796 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 1531 | 0.010 |
Why?
|
| Estradiol | 1 | 1982 | 1932 | 0.010 |
Why?
|
| Immunoassay | 2 | 1989 | 748 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1975 | 197 | 0.010 |
Why?
|
| Myofibrils | 1 | 1975 | 141 | 0.010 |
Why?
|
| Karyotyping | 1 | 1976 | 1172 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 1974 | 4814 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1990 | 3086 | 0.010 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 1994 | 18 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1974 | 18134 | 0.010 |
Why?
|
| Factor VIII | 1 | 1976 | 350 | 0.010 |
Why?
|
| History, 18th Century | 1 | 1975 | 207 | 0.010 |
Why?
|
| Histamine | 1 | 1976 | 499 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1994 | 112 | 0.010 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 1974 | 46 | 0.010 |
Why?
|
| Genes | 2 | 1991 | 1845 | 0.010 |
Why?
|
| Endocytosis | 2 | 1989 | 960 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 2918 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 2931 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 4920 | 0.010 |
Why?
|
| Methods | 1 | 1974 | 1075 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1974 | 341 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1976 | 501 | 0.010 |
Why?
|
| Lactation | 1 | 1976 | 395 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1900 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 1760 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1975 | 493 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1980 | 2424 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1994 | 429 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1976 | 1158 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 328 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1991 | 4625 | 0.010 |
Why?
|
| Regeneration | 3 | 1981 | 1506 | 0.010 |
Why?
|
| Gels | 1 | 1974 | 419 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1799 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 364 | 0.010 |
Why?
|
| Glutathione | 1 | 1995 | 582 | 0.010 |
Why?
|
| Physical Phenomena | 1 | 1992 | 48 | 0.010 |
Why?
|
| Brain | 1 | 1979 | 26912 | 0.010 |
Why?
|
| Potassium Isotopes | 1 | 1972 | 9 | 0.010 |
Why?
|
| Viscosity | 1 | 1993 | 335 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1972 | 86 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 317 | 0.010 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1992 | 74 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1991 | 4172 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1993 | 320 | 0.010 |
Why?
|
| Cell Death | 1 | 1997 | 1670 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1995 | 588 | 0.010 |
Why?
|
| Physics | 1 | 1992 | 90 | 0.010 |
Why?
|
| Acrylamides | 1 | 1974 | 260 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1983 | 5498 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 1978 | 536 | 0.010 |
Why?
|
| Biophysics | 1 | 1993 | 380 | 0.010 |
Why?
|
| Prostaglandin H2 | 1 | 1991 | 10 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1991 | 58 | 0.010 |
Why?
|
| Collateral Circulation | 1 | 1973 | 292 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1972 | 239 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1997 | 15740 | 0.010 |
Why?
|
| Serotonin | 1 | 1976 | 1041 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1983 | 3811 | 0.010 |
Why?
|
| Heart | 1 | 1984 | 4392 | 0.010 |
Why?
|
| Mathematics | 1 | 1992 | 708 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1990 | 46 | 0.010 |
Why?
|
| Isoproterenol | 2 | 1981 | 394 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 128 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1991 | 262 | 0.010 |
Why?
|
| Prostaglandins B | 1 | 1990 | 5 | 0.010 |
Why?
|
| Leukotriene A4 | 1 | 1990 | 24 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1990 | 197 | 0.010 |
Why?
|
| Fura-2 | 1 | 1990 | 107 | 0.010 |
Why?
|
| Prostaglandin D2 | 1 | 1990 | 110 | 0.010 |
Why?
|
| Dinoprost | 1 | 1990 | 138 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1990 | 202 | 0.010 |
Why?
|
| Melanoma | 1 | 1988 | 5695 | 0.010 |
Why?
|
| Eye | 1 | 1974 | 710 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1990 | 278 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1969 | 37 | 0.010 |
Why?
|
| Phospholipases A | 1 | 1990 | 204 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8157 | 0.010 |
Why?
|
| Trypsin | 2 | 1981 | 496 | 0.010 |
Why?
|
| Surface Properties | 1 | 1992 | 1158 | 0.010 |
Why?
|
| Benzofurans | 1 | 1990 | 142 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 1996 | 1335 | 0.010 |
Why?
|
| Organoids | 1 | 1975 | 729 | 0.010 |
Why?
|
| Pressure | 1 | 1992 | 1155 | 0.010 |
Why?
|
| Alkaloids | 1 | 1990 | 194 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1989 | 129 | 0.000 |
Why?
|
| Capillaries | 1 | 1972 | 745 | 0.000 |
Why?
|
| Isoquinolines | 1 | 1990 | 353 | 0.000 |
Why?
|
| Cell Count | 1 | 1992 | 1838 | 0.000 |
Why?
|
| Purpura | 1 | 1969 | 116 | 0.000 |
Why?
|
| Nigericin | 1 | 1987 | 10 | 0.000 |
Why?
|
| Introns | 1 | 1991 | 978 | 0.000 |
Why?
|
| Eicosanoids | 1 | 1990 | 278 | 0.000 |
Why?
|
| Polymyxin B | 1 | 1987 | 44 | 0.000 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1987 | 64 | 0.000 |
Why?
|
| Glycerol | 1 | 1989 | 277 | 0.000 |
Why?
|
| Models, Biological | 3 | 1993 | 9468 | 0.000 |
Why?
|
| Fluorescent Dyes | 2 | 1986 | 1914 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1991 | 863 | 0.000 |
Why?
|
| Apoptosis | 1 | 2004 | 9497 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1990 | 686 | 0.000 |
Why?
|
| Cyclosporins | 1 | 1987 | 216 | 0.000 |
Why?
|
| Ibuprofen | 1 | 1989 | 229 | 0.000 |
Why?
|
| Linoleic Acids | 1 | 1987 | 39 | 0.000 |
Why?
|
| Arsenicals | 1 | 1987 | 117 | 0.000 |
Why?
|
| Phosphatidylcholines | 1 | 1989 | 406 | 0.000 |
Why?
|
| Software | 1 | 2001 | 4420 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9531 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1972 | 2120 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1989 | 393 | 0.000 |
Why?
|
| Amiloride | 1 | 1987 | 116 | 0.000 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1987 | 122 | 0.000 |
Why?
|
| Intracellular Fluid | 1 | 1987 | 201 | 0.000 |
Why?
|
| Mutation | 2 | 2002 | 29950 | 0.000 |
Why?
|
| Pregnancy | 4 | 1980 | 29725 | 0.000 |
Why?
|
| DNA, Circular | 1 | 1987 | 97 | 0.000 |
Why?
|
| Immunoblastic Lymphadenopathy | 1 | 1986 | 40 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1986 | 119 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3804 | 0.000 |
Why?
|
| Insulin | 1 | 1981 | 6592 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1987 | 389 | 0.000 |
Why?
|
| Chloroquine | 1 | 1987 | 277 | 0.000 |
Why?
|
| Mitosis | 2 | 1985 | 1193 | 0.000 |
Why?
|
| Linoleic Acid | 1 | 1987 | 159 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1972 | 1521 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 20048 | 0.000 |
Why?
|
| Angiotensin I | 1 | 1985 | 56 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1985 | 53 | 0.000 |
Why?
|
| Wound Healing | 1 | 1977 | 2786 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1972 | 1840 | 0.000 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1986 | 490 | 0.000 |
Why?
|
| Blood Coagulation Tests | 1 | 1986 | 270 | 0.000 |
Why?
|
| Indium | 1 | 1984 | 46 | 0.000 |
Why?
|
| HLA-DP Antigens | 1 | 1984 | 28 | 0.000 |
Why?
|
| Angiotensinogen | 1 | 1985 | 161 | 0.000 |
Why?
|
| Necrosis | 1 | 1969 | 1612 | 0.000 |
Why?
|
| Dioxanes | 1 | 1984 | 36 | 0.000 |
Why?
|
| Incidence | 1 | 2003 | 21378 | 0.000 |
Why?
|
| Receptors, Immunologic | 1 | 1990 | 1434 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1985 | 557 | 0.000 |
Why?
|
| Cholesterol | 1 | 1993 | 2925 | 0.000 |
Why?
|
| Ethanol | 1 | 1990 | 1323 | 0.000 |
Why?
|
| Eicosapentaenoic Acid | 1 | 1987 | 613 | 0.000 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1984 | 377 | 0.000 |
Why?
|
| Skin Window Technique | 1 | 1982 | 22 | 0.000 |
Why?
|
| Interferon Type I | 1 | 1986 | 559 | 0.000 |
Why?
|
| Polylysine | 1 | 1982 | 131 | 0.000 |
Why?
|
| Gallic Acid | 1 | 1981 | 24 | 0.000 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1981 | 100 | 0.000 |
Why?
|
| Bucladesine | 1 | 1981 | 118 | 0.000 |
Why?
|
| Syndrome | 1 | 1988 | 3278 | 0.000 |
Why?
|
| Reserpine | 1 | 1981 | 60 | 0.000 |
Why?
|
| Hydroxydopamines | 1 | 1981 | 59 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1997 | 4317 | 0.000 |
Why?
|
| Chlorpromazine | 1 | 1981 | 111 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1981 | 246 | 0.000 |
Why?
|
| Temperature | 1 | 1987 | 2221 | 0.000 |
Why?
|
| Cations, Divalent | 1 | 1980 | 168 | 0.000 |
Why?
|
| Prostaglandins, Synthetic | 1 | 1980 | 24 | 0.000 |
Why?
|
| Ribonucleases | 1 | 1981 | 277 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 975 | 0.000 |
Why?
|
| Vena Cava, Inferior | 1 | 1983 | 458 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1987 | 1928 | 0.000 |
Why?
|
| Captopril | 1 | 1980 | 266 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1980 | 281 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 1558 | 0.000 |
Why?
|
| Propranolol | 1 | 1981 | 489 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1980 | 174 | 0.000 |
Why?
|
| Piperazines | 1 | 1990 | 2520 | 0.000 |
Why?
|
| Substance P | 1 | 1980 | 333 | 0.000 |
Why?
|
| Anions | 1 | 1979 | 137 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1976 | 6310 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1979 | 645 | 0.000 |
Why?
|
| Silver Nitrate | 1 | 1978 | 13 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1986 | 2937 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1985 | 2651 | 0.000 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1991 | 3201 | 0.000 |
Why?
|
| Aldehydes | 1 | 1979 | 171 | 0.000 |
Why?
|
| Leucine | 1 | 1979 | 548 | 0.000 |
Why?
|
| Estrogens | 1 | 1984 | 1520 | 0.000 |
Why?
|
| Leukopenia | 1 | 1978 | 212 | 0.000 |
Why?
|
| Dipeptides | 1 | 1979 | 410 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1980 | 932 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1969 | 3604 | 0.000 |
Why?
|
| RNA | 1 | 1987 | 2721 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1988 | 4223 | 0.000 |
Why?
|
| Epithelium | 1 | 1980 | 1605 | 0.000 |
Why?
|
| X-Rays | 1 | 1977 | 307 | 0.000 |
Why?
|
| Ferritins | 1 | 1979 | 598 | 0.000 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1977 | 881 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1982 | 1402 | 0.000 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1980 | 1025 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1978 | 1600 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1977 | 1536 | 0.000 |
Why?
|
| Hypertension | 2 | 1983 | 8595 | 0.000 |
Why?
|
| Testosterone | 1 | 1982 | 2469 | 0.000 |
Why?
|
| Microtubules | 1 | 1975 | 1072 | 0.000 |
Why?
|
| Adult | 1 | 1995 | 219847 | 0.000 |
Why?
|